Sofinnova Investments’s Insmed INSM Stock Holding History
Bought
Maintained
Sold
Other funds holding INSM
BBA
DGM
OAG
Sofinnova Investments's INSM Position: Q2 2026 in Review
Sofinnova Investments reduced its Insmed (INSM) stake by 54% in Q2 2026, selling an estimated $22.7M and leaving 158,398 shares worth $16.9M. The position accounts for 0.87% of the portfolio, ranked #29.
Sofinnova Investments first reported a position in INSM in Q1 2019 and has held it in 20 quarters since. The position peaked at $56.6M in Q1 2026. 665 funds tracked by Wall St. Rank hold INSM as of Q2 2026.
- Sofinnova Investments held 158,398 shares of Insmed worth $16.9M as of Q2 2026.
- Sofinnova Investments sold 187,677 Insmed shares in Q2 2026, an estimated $22.7M.
- Insmed made up 0.87% of Sofinnova Investments's portfolio in Q2 2026, its #29 holding.
- Sofinnova Investments first reported a position in Insmed in Q1 2019 and has held it in 20 quarters since.
- Sofinnova Investments's Insmed position peaked at $56.6M in Q1 2026.
- 665 funds tracked by Wall St. Rank held Insmed as of Q2 2026.
Based on Sofinnova Investments's 13F filing for Q2 2026, filed 14 Aug 2026.